Urogen Pharma (URGN) Insider Trading & Ownership $18.97 +1.64 (+9.46%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$18.40 -0.57 (-2.98%) As of 10/24/2025 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Urogen Pharma (NASDAQ:URGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$673.18K Get URGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Urogen Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. URGN Insider Buying and Selling by Quarter Urogen Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/8/2025Chris DegnanCFOSell2,203$16.85$37,120.55 9/8/2025Jason Drew SmithGeneral CounselSell1,520$19.11$29,047.20 9/8/2025Mark SchoenbergInsiderSell871$19.11$16,644.81 8/11/2025Mark SchoenbergInsiderSell10,000$17.69$176,900.00 7/28/2025Jason Drew SmithGeneral CounselSell7,522$19.14$143,971.08 7/28/2025Mark SchoenbergInsiderSell5,149$19.14$98,551.86 6/9/2025Mark SchoenbergInsiderSell5,162$7.37$38,043.94 1/31/2025Jason Drew SmithGeneral CounselSell7,379$11.14$82,202.06 1/31/2025Mark SchoenbergInsiderSell4,551$11.14$50,698.14 (Data available from 1/1/2013 forward) URGN Insider Trading Activity - Frequently Asked Questions Who is on Urogen Pharma's Insider Roster? The list of insiders at Urogen Pharma includes Chris Degnan, Jason Drew Smith, and Mark Schoenberg. Learn more on insiders at URGN. What percentage of Urogen Pharma stock is owned by insiders? 4.70% of Urogen Pharma stock is owned by insiders. Learn more on URGN's insider holdings. Which Urogen Pharma insiders have been selling company stock? The following insiders have sold URGN shares in the last 24 months: Chris Degnan ($37,120.55), Jason Drew Smith ($353,704.84), and Mark Schoenberg ($687,714.57). How much insider selling is happening at Urogen Pharma? Insiders have sold a total of 72,672 Urogen Pharma shares in the last 24 months for a total of $1,078,539.96 sold. Urogen Pharma Key ExecutivesMs. Elizabeth A. Barrett (Age 62)President, CEO & Director Compensation: $1.34MMr. Jason Drew Smith (Age 52)General Counsel, Chief Compliance Officer & Corporate Secretary Compensation: $864.19k2 recent tradesDr. Mark P. Schoenberg M.D. (Age 66)Chief Medical Officer Compensation: $639.83kMr. Dong Kim (Age 46)Chief Financial Officer Compensation: $546.68kVincent I. PerroneSenior Director of Investor RelationsMr. Bryon WornsonExecutive Vice President of Talent, Advocacy & CommunicationsDr. Marina KonortyExecutive Vice President of Research & Development and Technical OperationsMr. Jeffrey Bova M.B.A.Chief Commercial OfficerMr. James Ottinger R.ph.Executive Vice President of Regulatory Affairs & QualityDr. Polly A. Murphy D.V.M. (Age 59)M.B.A., Ph.D., Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies Amneal Pharmaceuticals Insider Trading Zai Lab Insider Trading Xenon Pharmaceuticals Insider Trading Ultragenyx Pharmaceutical Insider Trading uniQure Insider Trading CG Oncology Insider Trading Centessa Pharmaceuticals Insider Trading Disc Medicine Insider Trading Kiniksa Pharmaceuticals International Insider Trading Tarsus Pharmaceuticals Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles WesBanco Insiders Signal Confidence With Coordinated BuysBig Insider Sales at NVDA, DELL, TMUS Raise Questions—Or Do They?3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's Comeback This page (NASDAQ:URGN) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Urogen Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share Urogen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free URGN Stock Alerts